S3V Vascular Technologies Limited Unlisted Share Price
S3V Vascular Technologies Limited unlisted share price is ₹545 per share (indicative, as of 17 Oct 2026). Minimum ticket ₹25,000 (lot of 46 shares), the same for every company. Sector: Consumer. Status: unlisted, no DRHP on record.
All unlisted share prices: dated indicative prices for every company the desk tracks.
Updated 18 Oct 2026, 08:02 IST. Dated dealer references.
BuyUnlistedShares tracks 230 unlisted companies with dated prices; S3V Vascular Technologies Limited’s indicative price is ₹545 per share as of 18 Oct 2026, a lot of 46 shares.
Key facts
- Indicative price
- ₹545 per share
- Price as of
- 17 Oct 2026
- Minimum investment
- ₹25,000
- Lot size
- 46 shares
- Sector
- Consumer
- Listing status
- Unlisted
- Settlement
- Demat to demat; terms agreed in writing for each deal
- Last updated
- 18 Oct 2026, 08:02 IST
Indicative and dated. BuyUnlistedShares deals as principal.
Buying at a glance
- Minimum ticket
- ₹25,000
- Price shown
- Indicative, dated 17 Oct 2026
- Delivery
- Shares are credited to your demat account
In plain words
- Lock-in if it lists
- Shares bought before an IPO are generally locked in for six months from the IPO allotment date under SEBI rules. The issue documents set the exact terms.
- Demat
- Yes. ISIN INE0HGT01012: the shares sit in your own demat account and move demat to demat through NSDL or CDSL.
- IPO status
- Unlisted. No DRHP on record.
Facts only, not a rating or a recommendation.
Compare it against the full unlisted share price list: every company the desk quotes, each with a dated indicative price.
Indicative move: 0.0% over 3 months.
Key figures
| Market cap | ₹1,045.23 Cr |
|---|---|
| Minimum investment | ₹25,000 |
| Lot size | 46 |
| P/E ratio | 10,900x |
| ROE | 0.05% |
| Book value | ₹73.42 |
| Face value | ₹10 |
| 52-week high | ₹565 |
| 52-week low | ₹350 |
| ISIN | INE0HGT01012 |
| Dividend yield | — |
Financials (₹ Cr)
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 18.9 | 14.9 | 13.6 |
| PAT | 0.60 | -3.20 | 0.07 |
| EPS (₹) | 0.42 | -2.35 | 0.05 |
About the company
S3V Vascular Technologies Limited is an Indian medical device company that develops and manufactures advanced cardiovascular and critical-care products. Incorporated in 2011 and headquartered in Mysore, Karnataka, the company operates a fully integrated model that combines in-house research and development, proprietary engineering, and regulated manufacturing facilities.
Prices shown are indicative and dated. Unlisted shares are illiquid and values can move sharply.
Registered in Karnataka.
Registry
- ISIN: INE0HGT01012
- Depository: NSDL & CDSL
- Listed at: Unlisted
- Price as of: 17 Oct 2026
Company facts
| CIN | U33112KA2011PLC059915 |
|---|---|
| Incorporated | 2011 |
| ISIN | INE0HGT01012 |
| Face value | ₹10 |
| Registered office | Plot No. 65-D4, Hootagalli Industrial Area, Mysuru 570018, Karnataka, India |
| Shares outstanding | 1,91,78,590 |
| Lot size | 46 shares |
| Minimum units | 20 |
| DRHP | Not filed |
Financial statements (₹ Cr)
| Metric | FY21 | FY22 | FY23 | FY24 | FY25 | FY25 vs FY24 |
|---|---|---|---|---|---|---|
| Revenue | 16.13 | 20.91 | 18.9 | 14.93 | 13.55 | −9.2% |
| EBITDA | — | 5.8 | 3.7 | 2.5 | −0.57 | profit to loss |
| Profit before tax | — | 2.8 | 0.65 | −3.06 | 0.15 | loss to profit |
| Profit after tax | 1.7 | 2.7 | 0.6 | −3.2 | 0.07 | loss to profit |
| EPS (₹) | — | 2.08 | 0.42 | −2.35 | 0.05 | loss to profit |
| Net margin | — | — | — | −21.1% | 0.4% | +21.5 pts |
| Share capital | — | — | — | 19.18 | 19.18 | +0% |
| Reserves & surplus | — | — | — | 121.57 | 121.63 | +0% |
| Net worth | — | — | — | 140.75 | 140.81 | +0% |
| Fixed assets | — | — | — | 25.64 | 53.44 | +108.4% |
| Trade receivables | — | — | — | 37.08 | 42.18 | +13.8% |
| Trade payables | — | — | — | 4.36 | 5.72 | +31.2% |
| Cash from operations | — | — | — | −7.33 | −6.42 | +12.4% |
| Cash from investing | — | — | — | −30.25 | −31.14 | −2.9% |
| Cash from financing | — | — | — | 92.56 | −9.8 | profit to loss |
| Net cash generated | — | — | — | 54.97 | −47.37 | profit to loss |
Key ratios and valuation
| Measure | Value | Basis |
|---|---|---|
| Indicative price | ₹545 | dealer reference, 17 Oct 2026 |
| Market cap | ₹1,045.23 Cr | price × 1,91,78,590 shares |
| P/E | — | not meaningful |
| P/B | 7.42x | price ÷ book value ₹73.42 |
| EPS | ₹0.05 | per share, FY25 |
| Book value | ₹73.42 | per share, latest books |
| RoE | 0.05% | return on equity, latest FY |
| Debt / equity | 0.13 | latest balance sheet |
| Dividend yield | — | |
| Face value | ₹10 | per share |
| 52-week range | ₹350 – ₹565 | 289 dated quotes, last 12 months |
| Shares outstanding | 1,91,78,590 | per company record |
Shareholding pattern
| Category | Holder | % of equity |
|---|---|---|
| Promoters | N G Badari Narayan (Promoter) | 16.17% |
| Others | Kalindhi Narayan | 8.43% |
| Others | L&T Welfare Company Limited (ccps) | 7.41% |
| Promoters | Vijaya Gopal Nagaradagadde (Promoter) | 5.05% |
| Others | Vishnu Shreyas | 4.69% |
| Others | Srivatsa Sarang | 1% |
| Public | Others / Public | 57.25% |
Promoters 21.22% · Public 57.25% · Others 21.53%
Management and promoters
| Name | Designation | Experience |
|---|---|---|
| Badari Narayan Nagarada Gadde | Promoter / Managing Director & CEO | — |
| Vijaya Gopal Nagaradagadde | Director, Co-founder (r&d) | — |
| Nagarada Gadde Vishnu Shreyas | Whole Time Director / CFO (Operations) | — |
| Anuj Mehta | Company Secretary | — |
Business model
S3V Vascular Technologies Limited is an unlisted Indian medical-device company focused on the cardiovascular market and research and development in medical applications. Its FY2023-24 annual report describes three manufacturing plants in Mysuru: Plant No. 1 at Hootagalli for manufacturing and administration, Plant No. 2 at Hebbal, and Plant No. 3 at Hootagalli. The report says the company is developing critical electronic-based medical catheters such as FFR and IVUS products.
Its financial notes identify revenue from operations and say sales are recognised when significant risks and rewards of ownership pass to customers, generally on dispatch. The accounts also show dedicated product-development-cost projects including BIPP, micro catheter, stent coating, bio-observable stent, integration of hypotube, neuro and spinal cage projects. The issuer’s report presents these activities as its device-development, manufacturing and commercial-sales operations.
Corporate actions and events
| Date | Type | Detail | Ratio / amount | Source |
|---|---|---|---|---|
| Undated | Rating | An EGM notice was issued for a 26 April 2024 meeting to approve amended Articles incorporating the 4 March 2024 investment-agreement terms. (1 Apr 2024) | — | Desk note |
Reports and filings
No filings uploaded yet.
Annual reports
- S3V Vascular Technologies Limited annual report 2023-24 (PDF)
- S3V Vascular Technologies Limited annual report 2022-23 (PDF)
Frequently asked questions
What does S3V Vascular Technologies Limited do?
S3V Vascular Technologies is an Indian medical device company that develops and manufactures cardiovascular and critical-care products. Its portfolio includes drug-eluting and bare-metal stents, PTCA and neurovascular catheters, balloon dilatation systems, and other interventional devices, produced through an integrated in-house research and manufacturing model based in Mysore, Karnataka.
Is S3V Vascular Technologies listed on the stock exchanges, and how can its unlisted shares be purchased?
No. S3V Vascular Technologies is not currently listed on the NSE or BSE main board; it is a privately held, pre-IPO company whose shares trade in the unlisted market. Unlisted shares are generally bought through an over-the-counter transaction facilitated by an unlisted-shares dealer, with the shares transferred into the buyer's demat account after KYC and settlement.
What determines the indicative price of S3V Vascular Technologies unlisted shares?
Because the shares are not exchange-traded, there is no continuous official market price. The indicative price reflects negotiated demand and supply among buyers and sellers in the unlisted market, and it can differ across counterparties and dates. Factors that participants commonly reference include the company's financial performance, product pipeline, regulatory approvals, funding activity, and broader sentiment around any potential public listing.
What are the key fundamentals of S3V Vascular Technologies Limited?
S3V Vascular Technologies Limited carries CIN U33112KA2011PLC059915 and ISIN INE0HGT01012. It was incorporated in 2011, has a face value of ₹10 per share, and is registered in Mysore, Karnataka. These are factual identifiers; investors should review the company's latest audited financials and disclosures before forming any view.
What is the S3V Vascular Technologies Limited unlisted share price today?
The indicative over-the-counter reference price is ₹545 per share as of 17 Oct 2026. It is a dated dealer reference, refreshed every working day.
Is S3V Vascular Technologies Limited listed on a stock exchange?
Not yet. S3V Vascular Technologies Limited changes hands in the unlisted market, over the counter and settle into your demat account through NSDL and CDSL.
What is the minimum investment in S3V Vascular Technologies Limited?
The minimum ticket is ₹25,000, the same for every company on the site.
What is the ISIN of S3V Vascular Technologies Limited?
INE0HGT01012. Holdings are settled in demat form through NSDL and CDSL.
How do I buy S3V Vascular Technologies Limited unlisted shares?
Send an enquiry with the quantity you have in mind. The desk replies with a dated quote, the paperwork list and the demat steps, and the shares settle demat to demat into your own account.
Is there a lock-in if S3V Vascular Technologies Limited lists?
Pre-IPO shareholders other than promoters are generally locked in for six months from the date of IPO allotment under SEBI ICDR regulation 17. The final offer document sets the exact terms.
Sources
- S3V Vascular Technologies Limited annual report 2023-24 · FY 2023-24 · new.s3vvascular.com
- S3V Vascular Technologies Limited annual report 2022-23 · FY 2022-23 · new.s3vvascular.com
- BuyUnlistedShares indicative price series for S3V Vascular Technologies Limited, dated daily · since 21 Nov 2025 (289 dated quotes) · buyunlistedshares.com
How to cite this page: BuyUnlistedShares, “S3V Vascular Technologies Limited unlisted share price”, https://buyunlistedshares.com/unlisted-shares/s3v-vascular-technologies-limited, as of 18 Oct 2026.
Other Consumer unlisted shares
- A V Thomas & Co. Limited · ₹12,500
- Anglo French Drugs and Industries · ₹1,075
- Anheuser Busch Inbev India (AB InBev) · ₹555
- Apollo Fashion International · ₹44
- Arch Pharmalabs Limited · ₹85
- Auckland Jute Co. Limited · ₹189
Enquire to buy S3V Vascular Technologies Limited · Sell a holding
Indicative reference price, dated. BuyUnlistedShares is India's premium unlisted shares desk, run by Gayatri Financial Synergy LLP. In the market since 2002. Data as of 18 Oct 2026.
Before you buy: guides
- How to evaluate an unlisted company before investing
- How Unlisted Share Prices Are Discovered When There Is No Live Order Book
- The risks of buying unlisted and pre-IPO shares in India
- Unlisted Shares Lock-In Period: What Every Investor Must Know (2026)
- Can an NRI invest in unlisted shares in India?
All unlisted shares · IPO calendar · Research & learning · Send an enquiry · Calculators · Jobs · About · Contact · Privacy · Terms · Disclaimer · Grievance redressal
Guides: Start investing · Evaluate a company · How prices are set · Risks · Lock-in periods · After the IPO · Sell ESOPs · NRI investors · Buybacks · Choosing a platform
BuyUnlistedShares (BUS) · Gayatri Financial Synergy LLP (LLPIN ACU-4678) · SCO-39, 1st Floor, HUDA Market, Sector-7, Faridabad, Haryana 121006 · +91 916-916-59-59
